Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 02, 2021

SELL
$39.99 - $44.25 $12.2 Million - $13.5 Million
-304,656 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$42.17 - $46.84 $44,531 - $49,463
1,056 Added 0.35%
304,656 $13.1 Million
Q2 2020

Jul 31, 2020

SELL
$39.39 - $45.61 $113,600 - $131,539
-2,884 Reduced 0.94%
303,600 $13.2 Million
Q1 2020

May 05, 2020

SELL
$35.26 - $44.73 $42,664 - $54,123
-1,210 Reduced 0.39%
306,484 $12.4 Million
Q4 2019

Feb 05, 2020

BUY
$35.35 - $40.73 $73,704 - $84,922
2,085 Added 0.68%
307,694 $12.5 Million
Q3 2019

Nov 05, 2019

BUY
$33.91 - $36.46 $250,459 - $269,293
7,386 Added 2.48%
305,609 $0
Q2 2019

Jul 30, 2019

BUY
N/A
2,039 Added 0.69%
298,223 $10.5 Million
Q1 2019

May 02, 2019

SELL
N/A
-44,773 Reduced 13.13%
296,184 $10.2 Million
Q4 2018

Feb 01, 2019

BUY
N/A
104 Added 0.03%
340,957 $10.5 Million
Q3 2018

Nov 09, 2018

BUY
N/A
7,139 Added 2.14%
340,853 $10.4 Million
Q2 2018

Aug 10, 2018

BUY
N/A
1,083 Added 0.33%
333,714 $9.27 Million
Q1 2018

May 07, 2018

BUY
N/A
332,631 New
332,631 $9.51 Million

Others Institutions Holding RHHBY

About ROCHE HLDG LTD SPONS ADR


  • Ticker RHHBY
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 6,404,630,016
  • Market Cap $265B
More about RHHBY
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.